logo-loader

Tissue Regenix appoints group finance director

Published: 08:16 06 Jan 2017 GMT

Board room
Devlin will play a pivotal role in the strategic direction of Tissue Regenix over the coming years

Tissue Regenix Group PLC (LON:TRX) has named Paul Devlin as its group finance director and company secretary.

The regenerative medical devices company said Devlin brings a wealth of experience, having worked on both domestic and international mergers and acquisitions, business transformations, large and small scale business start ups, joint ventures and disposals throughout the last 20 years.

Prior to joining Tissue Regenix he was on an interim assignment for a private equity house and prior to this he was group finance director at Fletchers Bakeries Limited, which was sold to Finsbury Food Group PLC in October 2014.

“He will play a pivotal role in the strategic direction of Tissue Regenix over the coming years and the experience he brings will be invaluable to the company as we accelerate the breadth, depth and scope of our commercial activity," said Antony Odell, chief executive of Tissue Regenix.

Tissue Regenix unveils growth strategy and positive EBITDA milestone

Tissue Regenix Group PLC (AIM:TRX) CEO Danny Lee and CFO David Cocke discussed the company's 2023 operational and financial performance in an interview with Proactive's Stephen Gunnion. Tissue Regenix is a global leader in regenerative medicine, focusing on tissue-based scaffold technologies...

1 week, 2 days ago